In this season opener, we sit down with Krista Ewing, Senior Global Product Manager at Porex Corporation. As a renowned global leader in advanced porous solutions across various industries, including medical devices and writing instruments, it provides high-value solutions for product design challenges related to absorption, diffusion, filtration, and more.

Nathan chats with Krista about the journey behind the development of TruFlow, the infamous lateral flow product that emerged in response to the challenges faced during the COVID-19 pandemic. The conversation highlights the critical issues of inconsistency in glass fibre materials used for these tests, exacerbated by the soaring demand for COVID-19 diagnostics. Truflow was conceived as a solution to these challenges, aiming to provide more dependable and uniform materials for lateral flow tests, ultimately enhancing the accuracy and reliability of these crucial diagnostics.

Press play to learn about the journey and significance of TruFlow in revolutionising lateral flow testing and the impressive teamwork driving its success.

Hosted on Acast. See acast.com/privacy for more information.

This is the final episode of our 3-part series with the exciting POC diagnostics start-up, ProtonDx.

ProtonDx is founded on a decade of research and development at Imperial College London. Its vision is to develop ultra‑rapid, extremely precise, molecular testing for everyone at the point‑of‑need. In 2022, the business received a CE mark for its cutting-edge Dragonfly product. Now the ProtonDx team are looking to commercialise this essential testing kit.

In this episode, CM Life Science Business Manager, Nathan Sharpe, speaks to the Co-Founder and Chief Technology Officer of ProtonDx, Dr. Nicolas Moser. Nicolas earned an MSc at Imperial College London with distinction and received the Hertha Ayrton Centenary Prize (best MSc project) and the MSc Analogue and Digital Integrated Circuit Design Outstanding Achievement Prize (highest ranking MSc student).

In this episode, we cover the future of diagnostics from the perspective of an award-winning scientist and industry innovator. If you would like to learn more about the new possibilities with lab-on-chip, then be sure to give it a listen.

Hosted on Acast. See acast.com/privacy for more information.

In this next episode of our 3-part series with the exciting POC diagnostics start-up, Nathan sits down with Bob Enk, Chairman & President, and Dr. Jesus Rodriguez Manzano, Chief Scientific Officer for an exclusive chat about the future of diagnostics with ProtonDx.

Dr. Rodriguez Manzano has a strong interdisciplinary background in microbiology, molecular biology and bioengineering, and his research interest includes single-molecule technologies, machine learning applied to healthcare, and clinical diagnostics, with a particular interest in low- and middle-income countries. He is the author of over 90 scientific publications and 14 international patent applications and helped co-found ProtonDx just over 3 years' ago.

Bob Enk is Chairman and President at ProtonDx. An experienced investing pioneer and CEO with an alternative mindset and demonstrated history of innovation and growth across financial services and healthcare. After joining the business nearly 2 years ago to take it to the next level in its stratospheric growth, he offers insight into his industry experience interacting with key players and clients, working with strategic partners and major investors, and loads more.

From the stimulus for this impressive brand to the reality of using point-of-care to tackle infectious disease in 2023 and beyond. Listen to learn more about new possibilities with lab-on-chip,

the vision for developing ultra‑rapid, extremely precise, molecular testing for everyone at the point‑of‑need, and the plan to commercialise this essential testing kit.

Hosted on Acast. See acast.com/privacy for more information.